← The Wire
ORICNasdaq
Oric Pharmaceuticals, Inc.
Pharmaceutical Preparations · DE · CIK 1796280
Develops cancer therapies countering resistance mechanisms in hormone-dependent cancers, precision oncology, and tumor dependencies
red 8-K · 90d
$856M
Market cap
$10.15
Last close
+6.6%
1D
+13.7%
5D
1.1M
Volume
Price · last 39 sessions+5.5%
May 4L $7.50 · H $10.15Jun 29
125
Total filings
Jun 22, 2026
Last filing
12/31
Fiscal year end
8-KExecutive Change · Shareholder VoteJun 22, 202610-Q10-QMay 4, 20268-KResults of OperationsMay 4, 2026DEFA14ADEFA14AApr 28, 2026DEF 14ADEF 14AApr 28, 20268-KCompany UpdateMar 31, 20268-KCompany UpdateFeb 23, 2026424B5424B5Feb 23, 202610-K10-KFeb 23, 20268-KResults of OperationsFeb 23, 20268-KCompany UpdateDec 8, 20258-KReg FD DisclosureNov 13, 202510-Q10-QNov 13, 20258-KResults of OperationsNov 13, 202510-Q10-QAug 12, 20258-KResults of Operations · Exit / Disposal CostsAug 12, 20258-KShareholder VoteJun 13, 20258-KMaterial Agreement · Equity IssuanceMay 28, 202510-Q10-QMay 5, 20258-KResults of OperationsMay 5, 2025DEFA14ADEFA14AApr 23, 2025DEF 14ADEF 14AApr 23, 20258-KExecutive ChangeMar 14, 20258-KCompany UpdateFeb 25, 202510-K10-KFeb 18, 20258-KResults of OperationsFeb 18, 20258-KReg FD DisclosureJan 13, 202510-Q10-QNov 12, 20248-KResults of OperationsNov 12, 2024SC 13GSC 13GNov 8, 2024SC 13GSC 13GOct 22, 202410-Q10-QAug 12, 20248-KResults of OperationsAug 12, 20248-KShareholder VoteJun 14, 202410-Q10-QMay 6, 20248-KResults of OperationsMay 6, 2024DEFA14ADEFA14AApr 24, 2024DEF 14ADEF 14AApr 24, 20248-KExecutive ChangeMar 29, 202410-K10-KMar 11, 20248-KResults of OperationsMar 11, 2024SC 13GSC 13GFeb 1, 2024SC 13GSC 13GJan 30, 2024SC 13GSC 13GJan 29, 2024SC 13GSC 13GJan 25, 20248-KMaterial Agreement · Equity IssuanceJan 22, 20248-KResults of Operations · Reg FD DisclosureJan 9, 20248-KCompany UpdateDec 11, 202310-Q10-QNov 6, 20238-KResults of OperationsNov 6, 20238-KCompany UpdateOct 23, 202310-Q10-QAug 10, 20238-KResults of OperationsAug 10, 2023SC 13GSC 13GJul 7, 20238-KMaterial Agreement · Equity IssuanceJun 27, 20238-KShareholder VoteJun 15, 2023SC 13GSC 13GJun 12, 202310-Q10-QMay 8, 20238-KResults of OperationsMay 8, 2023DEFA14ADEFA14AApr 26, 2023DEF 14ADEF 14AApr 26, 20238-KBylaw AmendmentMar 24, 202310-K10-KMar 16, 20238-KResults of OperationsMar 16, 2023SC 13GSC 13GJan 20, 20238-KResults of Operations · Reg FD DisclosureJan 9, 20238-KCompany UpdateDec 21, 2022424B5424B5Dec 21, 202210-Q10-QNov 7, 20228-KResults of OperationsNov 7, 202210-Q10-QAug 11, 20228-KResults of OperationsAug 11, 2022SC 13GSC 13GJul 8, 20228-KShareholder VoteJun 21, 202210-Q10-QMay 9, 20228-KResults of OperationsMay 9, 2022DEFA14ADEFA14AApr 27, 2022DEF 14ADEF 14AApr 27, 20228-KReg FD DisclosureMar 21, 202210-K10-KMar 21, 2022
Insider Activity
In the 90 days to Feb 24, 2026: 4 sold $1.3M.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Feb 24, 2026 | Piscitelli DominicChief Financial Officer | Sell | 52,000 | $13.51 | $703K |
| Jan 16, 2026 | Heyman Richard A.Director | Sell | 3,500 | $12.00 | $42K |
| Jan 16, 2026 | Heyman Richard A.Director | Sell | 3,200 | $12.00 | $38K |
| Dec 16, 2025 | Chacko JacobPRESIDENT AND CEO | Sell | 33,374 | $9.06 | $302K |
| Dec 16, 2025 | Piscitelli DominicChief Financial Officer | Sell | 10,720 | $9.06 | $97K |
| Dec 16, 2025 | Multani Pratik SChief Medical Officer | Sell | 10,720 | $9.06 | $97K |
| Oct 6, 2025 | Chacko JacobPRESIDENT AND CEO | Sell | 37,461 | $12.32 | $462K |
| Oct 6, 2025 | Piscitelli DominicChief Financial Officer | Sell | 11,000 | $14.52 | $160K |
| Oct 1, 2025 | Chacko JacobPRESIDENT AND CEO | Sell | 53,001 | $12.05 | $639K |
| Sep 30, 2025 | Chacko JacobPRESIDENT AND CEO | Sell | 34,538 | $12.01 | $415K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
Similar companies
Comparable business profile · signals at a glance